Apyx Medical Corp
Apyx Medical Corp
Insider Sentiment (TTM):
Last Purchase:2024-08-13Last Sale:2023-06-26Shares Purchased (TTM):0Shares Sold (TTM):0
Institutional Sentiment:
As of:2026-03-31Institutional Shares Owned:20,758,431Shares Outstanding:41,095,000Institutional Ownership Pct.:50.51%
Earnings Market Reaction:
Filing Date:2026-05-07Price on Filing Date:N/APrevious Close:N/A% Change:N/A
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 31 | 32 | 25 | 29 | 31 | 32 | 28 | 33 | 37 | 44 | 22 | 18 | |||||
Accounts Receivable Net Current | 13 | 17 | 13 | 11 | 12 | 15 | 13 | 13 | 12 | 14 | 13 | 12 | |||||
Inventory Net | 10 | 9 | 9 | 8 | 8 | 8 | 9 | 9 | 10 | 10 | 11 | 11 | |||||
Prepaid Expense And Other Assets Current | 1 | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | |||||
Income Taxes Receivable | - | - | - | - | - | - | - | - | - | 0 | 0 | 8 | |||||
Assets Current | 55 | 58 | 49 | 50 | 52 | 56 | 52 | 57 | 62 | 70 | 50 | 53 | |||||
Other Receivables Net Current | - | - | - | - | - | - | - | - | - | 0 | 1 | 0 | |||||
Property Plant And Equipment Net | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Operating Lease Right Of Use Asset | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Finance Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Assets Noncurrent | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Assets | 63 | 67 | 57 | 58 | 60 | 65 | 61 | 65 | 71 | 79 | 59 | 62 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 3 | 3 | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 3 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Finance Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Long Term Debt Current | - | - | - | - | - | - | - | - | - | - | - | 9 | |||||
Liabilities Current | 9 | 12 | 11 | 11 | 10 | 11 | 10 | 11 | 11 | 13 | 10 | 19 | |||||
Long Term Debt Noncurrent | 35 | 35 | 35 | 34 | 34 | 34 | 34 | 34 | 33 | 33 | 9 | - | |||||
Operating Lease Liability Noncurrent | 4 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | |||||
Finance Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Contract With Customer Liability Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Other Liabilities Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities | 50 | 52 | 51 | 51 | 50 | 51 | 50 | 50 | 50 | 52 | 26 | 26 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity Inclu… | |||||||||||||||||
Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 104 | 104 | 94 | 93 | 93 | 92 | 84 | 83 | 82 | 81 | 78 | 77 | |||||
Retained Earnings Accumulated Deficit | -91 | -89 | -88 | -86 | -82 | -78 | -73 | -69 | -62 | -54 | -45 | -40 | |||||
Stockholders Equity | 13 | 15 | 6 | 7 | 11 | 14 | 11 | 15 | 20 | 27 | 34 | 37 | |||||
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockholders Equity | 63 | 67 | 57 | 58 | 60 | 65 | 61 | 65 | 71 | 79 | 59 | 62 | |||||
Allowance For Doubtful Accounts Receivable | - | - | - | - | - | - | - | 1 | 1 | 1 | 1 | 1 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | - | - | |||||
Inventory Valuation Reserves | 1 | 1 | 1 | 1 | 1 | 1 | 1 | - | - | 1 | - | - | |||||
Accumulated Depreciation Depletion And Amortizatio… | 4 | - | 4 | 4 | 4 | - | 4 | 4 | 4 | - | - | - | |||||
Preferred Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | |||||
Common Stock Shares Authorized | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | 75 | |||||
Common Stock Shares Issued | 42 | 42 | 38 | 38 | 38 | 38 | 35 | 35 | 35 | 35 | 35 | 35 | |||||
Shares Outstanding | 42 | 42 | 38 | 38 | 38 | 38 | 35 | 35 | 35 | 35 | 35 | 35 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
0/5
Search a metric to start building a table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
0/1
Search a metric to start building a visual
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 12.22% | 26.40% | - | - | - | - | - | - | - | - | - | - |
| 2025 | 32.20% | 83.05% | 115.25% | 1.53% | 3.06% | 63.78% | 19.70% | 2.69% | 18.51% | 6.67% | -11.30% | 15.80% |
| 2024 | -0.60% | -19.28% | -19.28% | 30.39% | 17.65% | 18.63% | 5.92% | 7.89% | -1.97% | -4.81% | 20.19% | 50.00% |
| 2023 | 50.22% | 12.28% | 12.72% | -10.89% | -36.63% | -52.87% | 41.21% | 58.79% | 37.58% | 10.61% | 13.64% | 21.21% |
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Metrics | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 5.80 | 5.00 | 4.44 | 4.72 | 5.45 | 5.26 | 5.46 | 5.33 | 5.87 | 5.52 | 4.87 | 2.78 | |||||
| Quick Ratio | 4.65 | 4.15 | 3.47 | 3.84 | 4.49 | 4.40 | 4.30 | 4.27 | 4.71 | 4.53 | 3.44 | 2.03 | |||||
| Working Capital | 45.35M | 46.77M | 37.81M | 39.35M | 42.34M | 45.72M | 42.60M | 46.03M | 51.37M | 57.62M | 39.86M | 33.86M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 3.89 | 3.51 | 8.44 | 6.99 | 4.65 | 3.52 | 4.42 | 3.42 | 2.46 | 1.94 | 0.77 | 0.70 | |||||
| Interest Coverage TTM | -0.77 | -1.15 | -1.63 | -2.10 | -2.60 | -3.19 | -4.02 | -4.99 | -5.02 | -6.96 | -12.76 | -23.77 | |||||
| Debt Ratio | 0.79 | 0.78 | 0.89 | 0.87 | 0.82 | 0.78 | 0.82 | 0.77 | 0.71 | 0.66 | 0.44 | 0.41 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.91 | 0.80 | 0.81 | 0.75 | 0.72 | 0.67 | 1.24 | 1.17 | 1.19 | 1.19 | 0.88 | 0.78 | |||||
| Days Sales Outstanding TTM | 79.65 | 111.40 | 99.17 | 94.00 | 93.13 | 111.94 | 63.13 | 60.51 | 53.80 | 57.57 | 78.89 | 86.23 | |||||
| Receivables Turnover TTM | 4.58 | 3.28 | 3.68 | 3.88 | 3.92 | 3.26 | 5.78 | 6.03 | 6.78 | 6.34 | 4.63 | 4.23 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | - | - | - | - | - | - | - | - | - | -0.54 | - | - | |||||
| Free Cash Flow Per Share TTM | -0.21 | -0.22 | -0.25 | -0.27 | -0.35 | -0.53 | -0.52 | -0.28 | -0.29 | -0.17 | -0.24 | -0.50 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 63.15% | 62.53% | 62.65% | 61.63% | 61.49% | 61.04% | 39.49% | 40.61% | 42.19% | 43.25% | 65.75% | 65.03% | |||||
| Operating Profit Margin TTM | -7.70% | -12.20% | -19.84% | -26.46% | -32.31% | -39.18% | -29.05% | -30.20% | -23.98% | -22.11% | -34.63% | -39.13% | |||||
| Net Profit Margin TTM | -16.46% | -21.22% | -30.38% | -37.13% | -42.55% | -48.98% | -38.26% | -37.91% | -29.90% | -23.97% | -30.28% | -34.50% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 18.22% | 9.86% | -35.49% | -37.77% | -37.91% | -38.38% | 47.63% | 57.56% | 72.47% | 75.38% | 3.23% | -7.78% | |||||
| Net Income Growth (1Y) | -54.25% | -52.41% | -48.78% | -39.05% | -11.65% | 25.90% | 86.57% | 73.17% | 9.63% | -19.28% | -20.50% | -7.10% | |||||
| EPS Growth (1Y) | -58.70% | -58.84% | -53.08% | -44.13% | -19.01% | 22.64% | 86.56% | 73.10% | 9.48% | -19.53% | -20.63% | -7.47% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -16.79 | -12.83 | -5.56 | -4.92 | -2.57 | -2.38 | -1.51 | -1.64 | -2.07 | -4.85 | -7.28 | -10.64 | |||||
| P/B TTM | 12.04 | 9.70 | 13.31 | 11.72 | 4.86 | 3.92 | 3.84 | 3.15 | 2.30 | 3.37 | 3.30 | 4.74 | |||||
| P/S TTM | 2.76 | 2.72 | 1.69 | 1.83 | 1.09 | 1.17 | 0.58 | 0.62 | 0.62 | 1.16 | 2.20 | 3.67 | |||||
| Market Cap | 154.49M | 143.83M | 80.93M | 85.04M | 51.78M | 56.16M | 42.96M | 46.42M | 47.12M | 90.71M | 110.86M | 174.18M | |||||
| Enterprise Value | 158.47M | 146.96M | 90.43M | 90.12M | 54.91M | 58.33M | 48.82M | 47.39M | 43.26M | 80.26M | 97.76M | 164.69M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -8.99M | -9.12M | -9.49M | -10.03M | -13.15M | -18.77M | -17.89M | -9.78M | -10.17M | -5.78M | -8.15M | -17.22M | |||||
| Net Debt | 3.97M | 3.13M | 9.49M | 5.08M | 3.14M | 2.17M | 5.86M | 970.00K | -3.86M | -10.45M | -13.11M | -9.50M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
2024-08-13Purchase
Owner: Hill, Matthew C
Title: Chief Financial Officer
Shares: 6,000
Price/Share: $1.13
Value: $6,780.00
Shares Owned: 8,500
Relationship: Officer
Ownership: Direct
2024-08-13Purchase
Owner: Hill, Matthew C
Title: Chief Financial Officer
Shares: 5,336
Price/Share: $1.13
Value: $6,029.68
Shares Owned: 7,836
Relationship: Officer
Ownership: Direct
2023-12-12Purchase
Owner: Hill, Matthew C
Title: Chief Financial Officer
Shares: 2,500
Price/Share: $2.19
Value: $5,475.00
Shares Owned: 2,500
Relationship: Officer
Ownership: Direct
2023-11-14Purchase
Owner: Goodwin, Charles D. Ii
Title: Chief Executive Officer
Shares: 50,000
Price/Share: $1.57
Value: $78,500.00
Shares Owned: 90,000
Relationship: Director,Officer
Ownership: Direct
2023-06-26Sale
Owner: Hornsby, Todd
Title: Executive Vice President
Shares: 15,000
Price/Share: $7.56
Value: $113,400.00
Shares Owned: -
Relationship: Officer
Ownership: Direct
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
No data available for chart
2026-03-31
50.51%
Inst. Shares: 20,758,431
Shares Outstanding: 41,095,000
2025-12-31
46.21%
Inst. Shares: 18,991,051
Shares Outstanding: 41,095,000
2025-09-30
36.67%
Inst. Shares: 15,069,591
Shares Outstanding: 41,095,000
2025-06-30
40.01%
Inst. Shares: 15,120,374
Shares Outstanding: 37,793,886
2025-03-31
42.78%
Inst. Shares: 15,204,988
Shares Outstanding: 35,542,000
Apyx Medical Corp (APYX) — SEC Financial Statements & Analysis
Apyx Medical Corp (APYX) is a surgical & medical instruments & apparatus company, incorporated in DE. Apyx Medical Corp trades on Nasdaq as: APYX. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Apyx Medical Corp reported a 18.22% year-over-year revenue growth, a Gross Profit Margin of 63.15% (TTM), a Debt-to-Equity ratio of 3.89x, a Price-to-Sales (P/S) ratio of 2.76x (TTM), a Price-to-Book (P/B) ratio of 12.04 (TTM), at a market cap of $154.49M. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 18.22%
- Gross Profit Margin TTM
- 63.15%
- Debt To Equity
- 3.89x
- P/S TTM
- 2.76x
- P/B TTM
- 12.04
- Market Cap
- $154.49M
Data as of 2026-03-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Apyx Medical Corp in?
Apyx Medical Corp (APYX) operates in the Surgical & Medical Instruments & Apparatus industry.
What is APYX's market cap?
Apyx Medical Corp (APYX) has a market capitalization of $154.49M as of 2026-03-31.
What exchange does APYX trade on?
Apyx Medical Corp (APYX) trades on the Nasdaq.
Where is Apyx Medical Corp incorporated?
Apyx Medical Corp is incorporated in DE.